Listen for Questions About Meds to Prevent RSV in Young Children
Nirsevimab-alip (Beyfortus) will be a new med to prevent respiratory syncytial virus (RSV) in young children.
You’ll hear nirsevimab called a vaccine...since it’s an intramuscular (IM) injection that provides protection against RSV. But it’s a monoclonal antibody that’s given in a clinic or hospital.
Nirsevimab joins palivizumab (Synagis)...another injectable monoclonal antibody to prevent serious illness from RSV.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote